Invitrogen JA – 799
This Rx-360 Audit Report contains the following scope:
Audit focused on foetal bovine serum (FBS) manufacture based in Australia at sponsor’s request.
New Zealand site was visited to include quality control and quality assurance processes
undertaken as part of Australian product manufacture and a general site inspection of FBS
facilities were also undertaken